Market Closed -
Swiss Exchange
11:31:37 2025-06-19 am EDT
5-day change
1st Jan Change
130.80 CHF
-0.76%
-3.68%
+22.70%
Medacta Enters Collaboration for RFID Technology in Healthcare Business
Published on 02/20/2024 at 05:26,
updated on 02/20/2024 at 05:32
Berenberg Sees Medacta Group as 'Buying Opportunity' Amid Tariff Challenges
Apr. 09
MT
Swiss Market Index Recovers; Baloise Gains
Mar. 25
MT
Medacta Group SA, 2024 Earnings Call, Mar 25, 2025
Mar. 25
Medacta Group SA Provides Earnings Guidance for the Year 2025
Mar. 25
CI
Medacta Group SA Reports Earnings Results for the Full Year Ended December 31, 2024
Mar. 24
CI
Anika Therapeutics Completes Divestiture of Parcus Medical to Medacta
Mar. 07
MT
Medacta Group Finalizes Purchase of Parcus Medical
Mar. 07
MT
Medacta Group SA acquired Parcus Medical, LLC from Anika Therapeutics, Inc..
Mar. 06
CI
Swiss stocks - Factors to watch on February 13
Feb. 13
RE
Medacta Group SA, 2024 Earnings Call, Feb 04, 2025
Feb. 04
Medacta Group Logs Higher Preliminary FY24 Revenue
Feb. 04
MT
Medacta Group SA Reports Unaudited Group Revenue Results for the Year Ended 31 December 2024
Feb. 04
CI
Swiss Market Index Advances Ahead of SNB's Rate Decision Day
24-09-25
MT
Medacta Group SA - Analyst/Investor Day
24-09-25
Medacta Group Reports Growth in H1 Attributable Profit, Revenue
24-09-25
MT
Medacta's Profitability at Risk Amid Expected Sales Slowdown in H1, Morgan Stanley Says
24-09-24
MT
Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2024
24-09-23
CI
Medacta Group, Think Surgical Partner in US for Robotic Total Knee Arthroplasty Solution
24-08-30
MT
Medacta Group, Mighty Oak Medical Settle Patent Dispute via New License Deal
24-08-28
MT
Medacta Group SA, H1 2024 Earnings Call, Jul 25, 2024
24-07-25
Medacta Group SA Provides Earnings Guidance for the Year 2024
24-03-13
CI
Medacta Group SA, 2023 Earnings Call, Mar 13, 2024
24-03-13
Medacta Group SA Reports Earnings Results for the Full Year Ended December 31, 2023
24-03-12
CI
Medacta Enters Collaboration for RFID Technology in Healthcare Business
24-02-20
MT
Medacta Group SA, 2023 Sales/ Trading Statement Call, Feb 02, 2024
24-02-02
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
MOVE: Dynamic Chart
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
More about the company
Last Close Price
139.24 EUR
Average target price
154.48 EUR
Spread / Average Target
+10.94%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
Select your edition
All financial news and data tailored to specific country editions